Biotech · Private company
Immunic AG
Track this companyFree. Adds Immunic AG to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- IMU-838 tabletsPhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- IMU-838 tabletsPhase 3 · Multiple Sclerosis, Relapsing-RemittingClinicalTrials.gov · fetched Nov 12, 2026
- IMU-838Phase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- IMU-838Phase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 12, 2022ClinicalTrials.gov NCT05201638 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 18, 2021ClinicalTrials.gov NCT05134441 · fetched Nov 12, 2026
- Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple SclerosisPHASE2 · UNKNOWN · started Sep 30, 2021ClinicalTrials.gov NCT05054140 · fetched Nov 12, 2026
- Phase 2 Dose-finding IMU-838 for Ulcerative ColitisPHASE2 · TERMINATED · started Mar 15, 2018ClinicalTrials.gov NCT03341962 · fetched Nov 12, 2026